Walgreens (WBA) is a publicly traded Healthcare sector company. As of May 20, 2026, WBA trades at $11.98 with a market cap of $10.37B and a P/E ratio of -1.64. WBA moved +0.55% today. Year to date, WBA is +11.13%; over the trailing twelve months it is flat. Its 52-week range spans $8.08 to $13.25. Analyst consensus is hold with an average price target of $23.57. Rallies surfaces WBA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes WBA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $11.98 |
| Market Cap | $10.37B |
| P/E Ratio | -1.64 |
| EPS | $-7.29 |
| Dividend Yield | 0.25% |
| 52-Week High | $13.25 |
| 52-Week Low | $8.08 |
| Volume | 452.08M |
| Avg Volume | 0 |
| Revenue (TTM) | $154.58B |
| Net Income | $-7.91B |
| Gross Margin | 17.13% |
31 analysts cover WBA: 0 strong buy, 5 buy, 17 hold, 9 sell, 0 strong sell. Consensus rating is hold. Average price target: $23.57.